An experimental oral therapy for idiopathic pulmonary fibrosis (IPF) has been tolerated well in an ongoing Phase 2 clinical trial, according to interim data announced by its developer GRI Bio. After reviewing interim data from 24 patients treated with GRI-0621 for six weeks, an independent data monitoring…
This column is scheduled to publish at 10 a.m. Eastern time on July 10, 2025. Four years earlier at this hour, I was undergoing a bilateral lung transplant at Inova Fairfax Hospital here in Virginia. I’d been moved into surgery at 3 a.m., about seven hours earlier. Today, I…
It’s been hotter than usual here in the mid-Atlantic. Temperatures in the upper 90s, flirting with 100 F, plus high humidity made it feel like 107 to 115 F. If I had to sum it up in a single word, I’d pick “miserable.” After my diagnosis of idiopathic…
The National Institutes of Health has awarded $219,000 to fund a project at the University of Texas at Tyler aimed at developing a treatment for radiation-induced pulmonary fibrosis (PF) which can occur after cancer radiation therapy. The study, led by Sreerama Shetty, PhD, a professor at UT Tyler, will…
Being diagnosed in January 2017 with idiopathic pulmonary fibrosis (IPF) and learning that the disease is chronic, progressive, and incurable was a lot for one day. Of course, I wanted a cure or better therapies to be available immediately. But what I came to learn during my journey is…
Starting this week and over the coming months, the Pulmonary Fibrosis Foundation (PFF) will be hosting the PFF Walk 2025 — an annual fundraiser to support its mission of funding research, increasing advocacy, and giving support to people affected by pulmonary fibrosis (PF). The goal of PFF Walk…
When your lungs betray you, your voice becomes your strongest tool. That’s what it means to live and speak through pulmonary fibrosis (PF). Living with PF or another rare disease involves managing various challenges that can affect time, emotional well-being, and physical health. The countless doctor appointments, procedures,…
Later this week, summer arrives. Shortly after that come the dog days of summer, usually recognized as July 3-Aug. 11. Those days are typically considered the hottest, most sultry of the year. For most of my life, I welcomed those muggy days of summer. But with my diagnosis…
Treatment with Trevi Therapeutics’ nalbuphine extended-release (ER) tablets significantly reduced daily coughing frequency in people with idiopathic pulmonary fibrosis (IPF) and chronic cough. That’s according to top-line data from the Phase 2b CORAL trial (NCT05964335), which is evaluating three doses of the experimental oral therapy against a…
Get regular updates to your inbox.
